Literature DB >> 24868882

The effects of Salacia reticulata on anti-cellular oxidants and melanogenesis inhibition in alpha-MSH-stimulated and UV irradiated B16 melanoma cells.

Prasit Suwannalert, Ryusho Kariya, Ikuko Suzu, Seiji Okada.   

Abstract

The purposes of this study were to investigate the inhibitory effects of Salacia reticulata Tul. root extract on cellular oxidants and melanogenesis in B16 melanoma cells. Cells treated with non-toxic doses of S. reticulata root extract were investigated for their effects on melanogenesis, cellular tyrosinase activity and cellular oxidant scavenging activity. The results indicated that S. reticulata extract inhibited melanin synthesis and tyrosinase activity in alpha-MSH-induced or UV-irradiated B16 melanoma cells in a dose dependent manner. Additionally, the extract also exhibited anti-cellular oxidants in UV-induced radical melanoma cells. Altogether, these results suggested that S. reticulata root extract has roles in suppression of melanogenesis and oxidant inhibition. S. reticulata root extract may be a potential source for the development of pharmaceutical products for treatment of skin hyperpigmentation disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24868882

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  3 in total

Review 1.  Anti-diabetic and Anti-hyperlipidemic Effects and Safety of Salacia reticulata and Related Species.

Authors:  Sidney J Stohs; Sidhartha Ray
Journal:  Phytother Res       Date:  2015-05-31       Impact factor: 5.878

2.  N-(4-methoxyphenyl) caffeamide-induced melanogenesis inhibition mechanisms.

Authors:  Yueh-Hsiung Kuo; Chien-Chia Chen; Po-Yuan Wu; Chin-Sheng Wu; Ping-Jyun Sung; Chien-Yih Lin; Hsiu-Mei Chiang
Journal:  BMC Complement Altern Med       Date:  2017-01-23       Impact factor: 3.659

3.  Inhibition of melanogenesis by Gaillardia aristata flower extract.

Authors:  Minkyung Kim; Seoungwoo Shin; Jung-A Lee; Deokhoon Park; Jongsung Lee; Eunsun Jung
Journal:  BMC Complement Altern Med       Date:  2015-12-24       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.